Shareholders approved the renewal of terms for directors Ryan Rhodes, Dr. Lance Willsey, Fran Schulz, Josh Levine, and David Horn. The 2025 statutory and consolidated financial statements were formally approved. Shareholders ratified amendments to the company bylaws, including updates to share capital, board structure, and meeting procedures. The appointment of AGILI3F as statutory auditor was renewed. Shareholders approved various delegations of authority to the Board regarding potential future capital increases and mergers. A total of 37,484,065 ordinary shares were represented and voted at the meeting.